Arkema announces the proposed divestment of Febex, a company specializing in phosphorus-based chemistry, to Belgian group Prayon. Febex is a global player in phosphorus derivatives (high purity phosphoric acid, sodium hypophosphite and derivatives), used primarily in electronics and in the pharmaceuticals industry. Part of the Performance Additives Business Line and with little integration within the Group’s other activities, Febex reported sales of approximately €30 million in 2021, employs ...